Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0
Sign in

MBCProject_5782_T1_RNA

· A

1b7f6057-7243-548a-ab23-404a1baf18b2

Score in workbench →

Clinical attributes

From the source cohort, normalized into canonical keys plus the project's native columns.

cancer_type
cancer_type_detailed
subtype
A
subtype
A

GSVA pathway preview (50 Hallmark scores)

MeasuredDerivedReference

Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.

Top 10 elevated

  • UV_RESPONSE_DN+0.220
  • MITOTIC_SPINDLE+0.120
  • HEDGEHOG_SIGNALING+0.090
  • PANCREAS_BETA_CELLS+0.090
  • WNT_BETA_CATENIN_SIGNALING+0.070
  • SPERMATOGENESIS+0.060
  • BILE_ACID_METABOLISM+0.020
  • ESTROGEN_RESPONSE_EARLY+0.020
  • NOTCH_SIGNALING-0.010
  • ANDROGEN_RESPONSE-0.020

Top 10 suppressed

  • REACTIVE_OXYGEN_SPECIES_PATHWAY-0.400
  • MTORC1_SIGNALING-0.390
  • UV_RESPONSE_UP-0.360
  • E2F_TARGETS-0.340
  • GLYCOLYSIS-0.330
  • INTERFERON_ALPHA_RESPONSE-0.320
  • PI3K_AKT_MTOR_SIGNALING-0.320
  • HYPOXIA-0.310
  • P53_PATHWAY-0.300
  • CHOLESTEROL_HOMEOSTASIS-0.290

Patient twins — nearest pathway neighbors

MeasuredDerived

10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.

9 twins match this tumor's tissue · 1 come from a different tissue of origin

#SampleCancer typeSubtypecos similarity
1SRR8518450
breast-umap@18
A0.884
2TCGA-A7-A0DC-01B-04R-A22O-07
breast-umap@18
D0.881
3SRR11296800
colon-landscapes@1
0.879
4TCGA-A7-A13G-01B-04R-A22O-07
breast-umap@18
D0.873
5s0102877
melanoma-umap@29
0.865
6C3N-03420
lung-landscapes@6
cohortA10.865
7MBCProject_0719_T1_RNA
breast-umap@18
A0.864
8SAMN03290913
melanoma-umap@29
0.864
9AUR-AFUN-TTP1-A-1-0-R-A741-41
breast-umap@18
D0.861
10BS_0Y66ZBWE
brain-umap@2
low-grade glioma0.860

Per-pathway drug coverage

ModeledCalibratedDerived

For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.

0 of 8 elevated pathways have at least one drug that meaningfully reverses them.

Pathway (elevated)tumor scoreBest drugreversal magnitude
UV_RESPONSE_DN0.220Inavolisib— uncovered
MITOTIC_SPINDLE0.120Inavolisib— uncovered
HEDGEHOG_SIGNALING0.090Inavolisib— uncovered
PANCREAS_BETA_CELLS0.090Cobimetinib— uncovered
WNT_BETA_CATENIN_SIGNALING0.070Inavolisib— uncovered
SPERMATOGENESIS0.060Inavolisib— uncovered
BILE_ACID_METABOLISM0.020Inavolisib— uncovered
ESTROGEN_RESPONSE_EARLY0.020Inavolisib— uncovered